Position in MRK
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,674,213
+$170,738 QoQ
Shares Held
20,811
-0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,406
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calamos Wealth Management LLC holds $79,224,350 across 11 Drug Manufacturers - General names. MRK ranks #4 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
31,177 | $37,394,632 | |
| 2 | JNJ |
Johnson & Johnson
|
118,126 | $30,000,460 | |
| 3 | ABBV |
AbbVie Inc.
|
15,919 | $4,005,857 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
20,811 | $2,674,213 | |
| 5 | PFE |
Pfizer Inc
|
65,212 | $1,570,304 | |
| 6 | AMGN |
Amgen Inc
|
2,408 | $871,984 | |
| 7 | AZN |
Astrazeneca PLC
|
4,208 | $797,920 | |
| 8 | NVS |
Novartis AG
|
4,898 | $767,614 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,674,213 | 20,811 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $2,503,475 | 20,812 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,030,465 | 19,290 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,322,820 | 15,761 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,140,695 | 14,410 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,619,270 | 18,040 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,991,987 | 20,024 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $15,842,982 | 139,512 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $15,044,299 | 121,521 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $18,078,997 | 137,014 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $14,618,709 | 134,092 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $13,922,031 | 135,231 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $2,237,181 | 19,388 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,032,261 | 19,102 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,186,491 | 19,707 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $1,707,415 | 19,826 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $1,141,448 | 12,520 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,020,209 | 12,434 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,257,125 | 16,403 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,208,970 | 16,096 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,285,926 | 16,535 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $1,270,752 | 16,484 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $1,454,812 | 17,785 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,307,209 | 15,759 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $4,390,257 | 56,773 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $4,697,185 | 61,050 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||